Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Lipshultz

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|November 17, 2001
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicityE H Herman, J Zhang, N Rifai, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2000
Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejectionA M Moran, S E Lipshultz, N Rifai, et al.
American Heart Journal|January 29, 2000
Design and implementation of the North American Pediatric Cardiomyopathy RegistryM A Grenier, S K Osganian, G F Cox, et al.
Pediatrics|December 4, 2001
Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter studyT L Miller, K A Easley, W Zhang, et al.
The New England Journal of Medicine|June 29, 1995
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancerS E Lipshultz, S R Lipsitz, S M Mone, et al.
Journal of the American College of Cardiology|November 20, 1998
Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, MarylandW W Lai, S E Lipshultz, K A Easley, et al.
Circulation|February 24, 2001
Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study GroupS E Lipshultz, K A Easley, E J Orav, et al.
Pediatric Cardiology|May 20, 2000
Electrocardiography and 24-hour electrocardiographic ambulatory recording (Holter monitor) studies in children infected with human immunodeficiency virus type 1. The Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV-1 Infection Study GroupA S Saidi, D S Moodie, A Garson, et al.
Journal of the American College of Cardiology|September 14, 1999
The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV diseaseN E Bowles, D L Kearney, J Ni, et al.
The New England Journal of Medicine|September 14, 2000
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study GroupS E Lipshultz, K A Easley, E J Orav, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|November 17, 2001
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicityE H Herman, J Zhang, N Rifai, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2000
Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejectionA M Moran, S E Lipshultz, N Rifai, et al.
American Heart Journal|January 29, 2000
Design and implementation of the North American Pediatric Cardiomyopathy RegistryM A Grenier, S K Osganian, G F Cox, et al.
Pediatrics|December 4, 2001
Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter studyT L Miller, K A Easley, W Zhang, et al.
The New England Journal of Medicine|June 29, 1995
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancerS E Lipshultz, S R Lipsitz, S M Mone, et al.
Journal of the American College of Cardiology|November 20, 1998
Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, MarylandW W Lai, S E Lipshultz, K A Easley, et al.
Circulation|February 24, 2001
Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study GroupS E Lipshultz, K A Easley, E J Orav, et al.
Pediatric Cardiology|May 20, 2000
Electrocardiography and 24-hour electrocardiographic ambulatory recording (Holter monitor) studies in children infected with human immunodeficiency virus type 1. The Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV-1 Infection Study GroupA S Saidi, D S Moodie, A Garson, et al.
Journal of the American College of Cardiology|September 14, 1999
The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV diseaseN E Bowles, D L Kearney, J Ni, et al.
The New England Journal of Medicine|September 14, 2000
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study GroupS E Lipshultz, K A Easley, E J Orav, et al.
Pageof 5